Advanced Hepatocellular Carcinoma Clinical Trials in Shanghai, Shanghai Municipality
5 recruitingShanghai, Shanghai Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study of BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.74 enrolled1 locationNCT06986785
Recruiting
Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment
Advanced Hepatocellular Carcinoma (HCC)
Fudan University150 enrolled1 locationNCT07147101
Recruiting
Phase 2
Phase 2 Study of WGI-0301 for Advanced HCC
Advanced Hepatocellular Carcinoma (HCC)
Zhejiang Haichang Biotech Co., Ltd.60 enrolled4 locationsNCT06309485
Recruiting
Early Phase 1
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital37 enrolled1 locationNCT06418659
Recruiting
Phase 2
Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
Fudan University25 enrolled1 locationNCT05057845